A Phase III Study of Postoperative Radiation Therapy (IMRT) +/- Cetuximab for Locally Advanced Resected Head and Neck Cancer

This randomized phase III trial is studying radiation therapy to see how well it works compared with radiation therapy given together with cetuximab in treating patients who have undergone surgery for locally advanced head and neck cancer.

Study phase: III

Basic eligibility criteria:
Please contact the study coordinator for additional eligibility information.

Adults 18 and older with head and neck cancer

Primary disease category: Cancer

Secondary disease categories: Cancer, Head & Neck Cancers

Sponsor: NRG Oncology

Projected enrollment dates: June 2016 to June 2019

Official study title: A Phase III Study of Postoperative Radiation Therapy (IMRT) +/- Cetuximab for Locally Advanced Resected Head and Neck Cancer

ClinicalTrials.gov page:
http://www.clinicaltrials.gov/show/NCT00956007